Literature DB >> 22835475

Ovarian cancer G-protein-coupled receptor 1 induces the expression of the pain mediator prostaglandin E2 in response to an acidic extracellular environment in human osteoblast-like cells.

Juqiang Wang1, Yu Sun, Hideaki Tomura, Fumikazu Okajima.   

Abstract

Although bone pain in osteoporosis and skeletal metastasis is an expected consequence of fracture, there are other underlying causes responsible. Our study demonstrated that ovarian cancer G-protein-coupled receptor 1 detected extracellular protons in MG63 cells, and regulated osteoblast functions, such as prostaglandin E2 production, in response to acidic circumstances. In this work, we measured inositol phosphate production, intracellular Ca(2+) concentration, prostaglandin E2 production, and cyclic adenosine monophosphate accumulation in MG63 cells exposed to extracellular acidification. Extracellular acidity induced a transient increase in Ca(2+) concentration and inositol phosphate production. Acidification also induced prostaglandin E2 production, resulting in cyclic adenosine monophosphate accumulation. A small interfering RNA specific for the ovarian cancer G-protein-coupled receptor 1 markedly inhibited these proton-induced actions in MG63 cells. These results indicated that the involvement of ovarian cancer G-protein-coupled receptor 1 in acidic extracellular environment may be an underlying mechanism responsible for bone pain in osteoporosis or bone metastasis without clinically proved fractures.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835475     DOI: 10.1016/j.biocel.2012.07.015

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis.

Authors:  Cheryl de Vallière; Katharina Bäbler; Philipp Busenhart; Marlene Schwarzfischer; Chiaki Maeyashiki; Cordelia Schuler; Kirstin Atrott; Silvia Lang; Marianne R Spalinger; Michael Scharl; Pedro A Ruiz-Castro; Martin Hausmann; Gerhard Rogler
Journal:  Inflamm Intest Dis       Date:  2021-07-19

2.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

3.  Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.

Authors:  Xi-Ping Huang; Joel Karpiak; Wesley K Kroeze; Hu Zhu; Xin Chen; Sheryl S Moy; Kara A Saddoris; Viktoriya D Nikolova; Martilias S Farrell; Sheng Wang; Thomas J Mangano; Deepak A Deshpande; Alice Jiang; Raymond B Penn; Jian Jin; Beverly H Koller; Terry Kenakin; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2015-11-09       Impact factor: 49.962

Review 4.  GPR68: An Emerging Drug Target in Cancer.

Authors:  Shu Z Wiley; Krishna Sriram; Cristina Salmerón; Paul A Insel
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.